Patent · US Active

Compounds and methods for treating bacterial infections

US11046694B2 · kind B2 · utility

0Cited by

7References

26Claims

0Family size

Assignee

Entasis Therapeutics, Inc. · US

Inventors

Janelle Comita-Prevoir · Northborough, US
Thomas Francois Durand-Reville · Belmont, US
Satenig Guler · Waltham, US
Jan Romero · Cambridge, US
Mark Sylvester · Waltham, US
Ruben Tommasi · Whitehouse Station, US
Camilo Velez-Vega · Waltham, US
Xiaoyun Wu · Chesterfield, US
Jing Zhang · Wantage, US

Key dates

Filing date	May 8, 2018
Grant date	Jun 29, 2021
Priority date	—
Expiry date	May 8, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are antibacterial compounds represented by Formula I, or a pharmaceutically acceptable salt thereof, wherein X, Y, R4, R5, and R6 are as defined herein. Also provided are pharmaceutical compositions comprising the compounds of Formula I.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.